Statin-related side effects: the recent Lancet publication is biased toward false-negatives

Shouldn’t these randomized trials be designed to be powered to detect adverse outcomes? Are they not primarily powered to detect favorable effects? Sorry if my question is inane, but my knowledge of and experience with double-blind randomized controlled trials is limited